Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  TRANSGENE    TNG   FR0005175080

TRANSGENE

 (TNG)
793
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on TRANSGENE
10h ago TRANSGENE: Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical ..
4d ago TRANSGENE: Announces its Invesment in ElsaLys Biotech, a New Antibody Company C..
6d ago TRANSGENE: Announces that Clinical Data with Pexa-Vec will be Presented at the ..
04/29 TRANSGENE: Promising Final Data from the Phase 2 HCVac Trial of TG4040 Presente..
04/29 TRANSGENE: Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV ..
04/22 TRANSGENE: First Quarter 2013 Financial Report
04/17TRANSGENE SA: quaterly sales release
04/08 TRANSGENE: to Present New Data on TG1050 and TG4040 to Treat Chronic Hepatitis ..
03/25DJSanofi, Transgene Sign Joint Venture on Immunotherapy Treatments
03/25 TRANSGENE: Sanofi and Transgene Announce Innovative Long-Term Collaboration for..
03/21 TRANSGENE: Annual Results 2012 and Business Update
03/19TRANSGENE SA: quaterly earnings release
02/26 TRANSGENE: to Present at the Cowen & Company 33rd Annual Healthcare Conference
01/16 TRANSGENE: Announces its Financial Calendar for 2013
2012 TRANSGENE: to Collaborate with the EORTC on a Phase 2b Trial with TG4001 in Hea..
2012 TRANSGENE: Third Quarter Financial Report
2012 TRANSGENE: Third Quarter 2012 Financial Report
2012 TRANSGENE: Announces the Recruitment of Dr. Nathalie Adda as Chief Medical Offi..
2012 TRANSGENE: Jennerex and Transgene Present Positive Clinical Data from Phase 2 T..
2012 TRANSGENE: Reports 2012 Half Year Results
2012 TRANSGENE: Start of Operations in the 50:50 Chinese Joint Venture Between Tasly..
2012 TRANSGENE: Jennerex and Transgene Announce First Patient Treated In Phase 2 Cli..
2012 TRANSGENE: Announces Presentations Relating to TG4010 and JX594/TG6006 at Annua..
2012 TRANSGENE: Reports Randomized Phase 2b Data with Its Therapeutic HPV Vaccine TG..
2012 TRANSGENE: Reports Positive Follow Up Phase 2 Data on Its HCV Therapeutic Vacci..
2012 TRANSGENE: First Quarter 2012 Financial Report
2012 TRANSGENE: Transgene's New Therapeutic Vaccine Candidate (TG1050) to Treat Chro..
2012 TRANSGENE: and Jennerex Announce First Patient Treated in Phase 1/2 Clinical Tr..
2012 TRANSGENE: Reports Full Year 2011 Results
2012 TRANSGENE: Creates a Subsidiary in China and signs Immunocan
2012 TRANSGENE: Creates a Subsidiary in China and signs Immunocan, a European Commis..
2011 TRANSGENE: and Jennerex Announce First Patient Treated
2011 TRANSGENE: and Jennerex Announce First Patient Treated in Phase 2a Clinical Tri..
2011 TRANSGENE: and the French League against Cancer Enter Partnership
2011 TRANSGENE: and the French League Against Cancer Enter Partnership to Accelerate..
2011 TRANSGENE: Transgene’s Therapeutic HCV Vaccine TG4040 Combined with Commonly Us..
2011 TRANSGENE: Transgene's Therapeutic HCV Vaccine TG4040 Combined with Commonly Us..
2011 TRANSGENE: and Jennerex Announce Final Data at AASLD From JX594/TG6006 Randomiz..
2011 TRANSGENE: and Jennerex Announce the First Patient Randomized in Phase IIb Clin..
2011 TRANSGENE: Updates on the Therapeutic Vaccine TG4010 Developed in Lung Cancer
2011 TRANSGENE: Third Quarter 2011 Financial Report
2011 TRANSGENE: Announces Important Update on its HCVac Study with its Therapeutic V..
2011 TRANSGENE: Reports 2011 Half Year Results
2011 TRANSGENE: Publishes Phase I Clinical Data of its HCV Immunotherapy Product in ..
2011 TRANSGENE: Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Tria..
2011 TRANSGENE: and Vivalis enter a commercial license and collaboration agreement f..
2011 TRANSGENE: and VIVALIS Enter Into a Commercial License and Collaboration Agreem..
2011 TRANSGENE: Held its First R&D Day
2011 TRANSGENE: Jennerex and Transgene Present Positive JX594/TG6006 Randomized Phas..
2011 TRANSGENE: Innate Pharma and Transgene Announce the Creation of Platine Pharma ..
2011 TRANSGENE: First Quarter 2011 Financial Report
2011 TRANSGENE: Transgene, ChronTech Pharma and Inovio Pharmaceuticals to Collaborat..
2011 TRANSGENE: Jennerex and Transgene Announce Presentation of Phase 1 Data Demonst..
2011 TRANSGENE: Jennerex and Transgene Announce the Presentation of Positive Clinica..
2011 TRANSGENE: Announces Completion of Enrolment in HCVac (Phase II Trial) of TG404..
2011 TRANSGENE: Reports Full Year 2010 Results
2011 TRANSGENE: Announces the Termination by Roche of the License Agreement on TG400..
2011 TRANSGENE: Signs an Agreement with Beckman Coulter for the Development of a Com..
2010 TRANSGENE: Jennerex and Transgene Announce Initiation of Clinical Trial of Intr..
Advertisement
Chart
Duration : Period :
TRANSGENE Technical Analysis Chart | TNG | FR0005175080 | 4-Traders
Income Statement Evolution
TRANSGENE : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.